• MediStar Health

     

    Digital Health Consultations with Preferred US Oncologists

     

     

     

  • Did You Know?

     

     

     

    Health services in China are ranked 92 out of 188 countries based on the UN criteria (Cuba 66 and Mexico 69)

     

     

     

  • Bridging the Access Gap Through Digital Solutions

    Expertise at your fingertips

    What we do

     

    We offer high quality medical second opinions with the world's leading physicians. Our services are delivered through synchronous video consultations on our HIPAA compliant platform. The curated network of physicians guide optimal treatment plans and minimize misdiagnosis, so you can access medical expertise at your fingertips from anywhere in the world.

     

     

  • How It Works

    Easy | Convenient | Fast

    Ask

    Care Team

    Describe your medical condition and concerns securely on our website, mobile app, our official Wechat account, or over the phone

    Upload

    Your Medical Records

    Collect and send your medical records, including lab report, imaging files, hospital records, etc. We will organize and translate all the files

    Schedule

    An Appointment

    Select an oncologist with expertise in your disease. Cut weeks or months of waiting time down to 3-5 days so you can get care sooner

    Access

    Top Physicians

    Together with our medical interpreter, you can speak with a top specialist by secure video to ensure best possible diagnosis and the right treatment

  • Patient Success Stories

    Physician Quality Matters

    Emily Gao, 16 yrs - Southern China

    "I was scared, scared that college may never happen, scared that my life might be over."

    • After experiencing some unexplained chest pain one day at school, Emily's parents took her to the hospital.
    • Emily was then diagnosed with Diffuse Large B Cell Lymphoma, a fast-growing and aggressive type of cancer.
    • Both her primary physician and a specialist from Beijing suggested the stem cell transplant which would increase her five-year survival rate to 60%, but she would be infertile after the treatment and there is a risk of blood infection.
    • Her parents would need to sell their apartment to pay for the treatment.

    Silver Lining: World-class Care

    Experts who consult on second opinions include the top 0.1% of physicians in the US

    • Facing the difficult medical decision, Emily's parents wanted to evaluate the treatment plan with international specialists, and reached out to MediStar.
    • MediStar matched Emily with two oncologists - the clinical director of bone and marrow transplant from the Johns Hopkins Hospital and a hematologist who specializes in pediatric lymphoma. 
    • Both doctors rejected the stem cell transplant and recommended a chemotherapy regimen. 
    • After 6 cycles of chemo, Emily fully recovered.
    • "We saved close to 1 million RMB of treatment cost, but most importantly, my daughter was able to avoid the unnecessary procedures with very serious consequences." 
  • Our Specialists Include:

    Tomasz Beer, MD

    Grover C. Bagby Endowed Chair for Prostate Cancer Research Professor of Medicine

    Dr. Beer specializes in the medical care of prostate cancer patients. He has been involved in more than 100 clinical trials and has led studies that tested new drugs in humans for the first time as well as large global studies that challenge the current standard of care.

     

    EDUCATION & TRAINING

    Hematology and Medical Oncology Fellowship: Oregon Health Sciences University, Portland

    Medical School: The John's Hopkins University School of Medicine

    Abraham Chachoua, MD

    Co-Director of Gastrointestinal Malignancies at Mount Sinai's Comprehensive Cancer Center

    Board certified in medical oncology and hematology, Dr. Pizzolato has a specific interest in new therapies and immunotherapies, and currently serves as a principle investigator for many clinical trials.

     

    EDUCATION & TRAINING

    Hematology and Oncology Fellowship: Memorial Sloan Kettering Cancer Center

    Residencies: Internal Medicine, Columbia-Presbyterian Hospital, New York, NY

    Medical School: Mount Sinai School of Medicine, New York, NY

    Elizabeth Poynor, MD, PhD

    Previous Director of Translational Research Memorial Sloan Kettering Cancer Center

    Dr. Poynor's surgical practice focuses on the management of complex gynecologic surgical issues in women with benign and malignant conditions. She was noted a Top Doctor for the New York Metro Area for gynecologic oncology.


    EDUCATION & TRAINING

    Fellowship: Memorial Sloan Kettering Cancer Center, New York, NY

    Medical School: Columbia University College of Physicians and Surgeons, New York, NY

     

    Elisa Krill-Jackson, MD FACP

    Director Breast Cancer Genetics Program Mt. Sinai Comprehensive Cancer Center

    Dr. Elisa Krill-Jackson is a medical oncologist at Mount Sinai's Women's Centered Care Program and has a special interest in women's cancers, including breast and ovarian cancer. Dr. Krill-Jackson has led multiple clinical trials for breast cancer at Mount Sinai and is the director of the genetic testing program for hereditary breast and ovarian cancer.

     

    EDUCATION & TRAINING

    Fellowship: New England Medical Center, Boston, MA
    Medical School: University of Michigan, Ann Arbor, MI
     

  • Join Our Network of Oncologists

    Bridging the Access Gap

    Get Started Today

    We are continuing to expand our network of physicians and partnered organizations who are interested in international medicine. We invite you to speak to a team member about developing a partnership or joining our team.

    claire.wang@medi-star.com

  • Healthcare Gap between China and the U.S.

    Facts from NIH and China's National Cancer Prevention and Research Center

    30% vs 70%

    Five-year cancer survival rate:
    About 30% in China

    About 70% in the US

     

    610k vs 156k

    Estimated deaths due to lung cancer in 2017:

    610,000 in China

    156,000 in the US

     

    4.3 million vs 1.7 million

    The number of new cancer patients in 2015:

    4.3 million in China

    1.7 million in the US

    33% vs 15%

    Misdiagnosis rate:

    33% in China

    15% in the US

  • About Us

    Our Mission

    At MediStar, we believe every one should have the option to gain access to better care. We empower patients who wait in endless lines to get five minutes with a physician, who struggle to get any credible information online, who are about to spend their life-time savings on a treatment they are not sure will work. We are here to help wherever you are.

     

    “Platforms like MediStar are innovative offerings that become realities in the midst of major challenges specific to how healthcare is accessed in China."

    - Forbes

  • Get Started

    See Which Doctor is Right for You

  • Contact Us

    28 East Yuyuan Road, Donghai SOHO Building 3-G, JingAn, Shanghai, China

     

    136 Jinbi Road, ZM Health Management Center, Kunming, China